europeventures News

Emerging-market stocks are to produce higher returns than their developed-market equivalents as economic growth and currency gains favour the riskier assets according to a shareholder newsletter from “Europe Ventures”.

“Europe Ventures” are reportedly refining portfolios to allow for what they see as recession-proof growth in agricultural solutions companies, against a backdrop of the global downturn.

Venture Capitalists “Europe Ventures” have apparently confirmed to clients their proposed backing for a revolutionary blood-thinning product from London-based AstraZeneca Plc, following a series of successful trials.

“EuropeVentures”, Goldman Sachs fronts a consortium to buy Japanese them park.

“EuropeVentures”, Survey predicts consumer end of year spending will boost economy.